Cargando…
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
BACKGROUND: Yes-associated protein (YAP1) is frequently reported to function as an oncogene in many types of cancer, but in breast cancer results remain controversial. We set out to clarify the role of YAP1 in breast cancer by examining gene and protein expression in subgroups of patient material an...
Autores principales: | Lehn, Sophie, Tobin, Nicholas P, Sims, Andrew H, Stål, Olle, Jirström, Karin, Axelson, Håkan, Landberg, Göran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937431/ https://www.ncbi.nlm.nih.gov/pubmed/24559095 http://dx.doi.org/10.1186/1471-2407-14-119 |
Ejemplares similares
-
Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer
por: Busch, Susann, et al.
Publicado: (2012) -
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
por: Paulsson, Janna, et al.
Publicado: (2016) -
Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009) -
Cyclin D1, Id1 and EMT in breast cancer
por: Tobin, Nicholas P, et al.
Publicado: (2011) -
Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
por: Borgquist, Signe, et al.
Publicado: (2007)